Annex Advisory Services LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 37.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 90,943 shares of the medical equipment provider's stock after purchasing an additional 24,750 shares during the period. Annex Advisory Services LLC's holdings in Intuitive Surgical were worth $36,166,000 at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in ISRG. Draper Asset Management LLC raised its stake in shares of Intuitive Surgical by 41.9% in the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider's stock worth $2,848,000 after buying an additional 1,485 shares during the period. Deutsche Bank AG grew its stake in shares of Intuitive Surgical by 9.6% during the 4th quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider's stock valued at $862,108,000 after acquiring an additional 132,966 shares during the period. Oppenheimer Asset Management Inc. grew its stake in shares of Intuitive Surgical by 29.3% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider's stock valued at $40,255,000 after acquiring an additional 16,119 shares during the period. KBC Group NV increased its holdings in Intuitive Surgical by 4.7% in the 4th quarter. KBC Group NV now owns 420,593 shares of the medical equipment provider's stock worth $238,207,000 after acquiring an additional 18,697 shares in the last quarter. Finally, Jag Capital Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $18,771,000. Institutional investors own 83.64% of the company's stock.
Intuitive Surgical News Summary
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Intuitive Surgical’s second-quarter results exceeded expectations: revenue rose 18.4% year over year to $2.89 billion, while EPS reached $2.80 versus the $2.48 consensus estimate. Higher margins, continued adoption of its da Vinci and Ion platforms, and long-term demand for robotic-assisted surgery support the bullish case. Intuitive Surgical Just Beat Earnings
- Positive Sentiment: A bullish investor cited Intuitive Surgical’s potential once-per-decade hardware replacement cycle and approximately $8.6 billion cash position, arguing that the more than 30% year-to-date decline could create an attractive long-term entry point. The Number One Reason I Keep Buying Intuitive Surgical
- Neutral Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus and an average price target of $509.02. However, several firms recently lowered their targets, reflecting greater caution after the earnings report.
- Neutral Sentiment: Reported short interest was zero shares, implying no measurable short-selling pressure. The figure appears unusual and may reflect incomplete or unreliable data rather than a meaningful market signal.
- Negative Sentiment: Despite the earnings beat, investors remain concerned about slowing domestic procedure growth and whether the company’s roughly 46 P/E adequately reflects its growth prospects. Those concerns have contributed to the stock’s recent weakness. Intuitive Surgical Earnings and Valuation Analysis
- Negative Sentiment: Director Amy L. Ladd sold 472 shares across August 10–11, reducing her holdings by a substantial percentage, while EVP Gary Loeb sold 400 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their significance as a discretionary bearish signal but may still weigh modestly on sentiment.
Intuitive Surgical Trading Up 2.0%
Shares of ISRG stock opened at $401.23 on Wednesday. The stock has a market capitalization of $141.75 billion, a price-to-earnings ratio of 45.96, a price-to-earnings-growth ratio of 2.84 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The stock's 50-day moving average price is $392.47 and its 200-day moving average price is $443.35.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm's revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.81 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.
Analyst Ratings Changes
Several equities analysts have weighed in on the stock. Bank of America lowered their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a report on Friday, June 12th. Sanford C. Bernstein reduced their price objective on shares of Intuitive Surgical from $750.00 to $685.00 and set an "outperform" rating for the company in a research note on Friday, July 17th. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $525.00 to $500.00 and set an "outperform" rating on the stock in a research report on Friday, July 17th. Stifel Nicolaus lowered their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a "buy" rating on the stock in a research note on Friday, July 17th. Finally, HSBC downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 target price for the company. in a report on Thursday, July 30th. Twenty investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $509.02.
View Our Latest Analysis on ISRG
Insider Transactions at Intuitive Surgical
In related news, SVP Iman Jeddi sold 5,625 shares of the business's stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the company's stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the sale, the director directly owned 179 shares in the company, valued at approximately $70,364.90. The trade was a 28.69% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,106 shares of company stock valued at $2,949,518 in the last ninety days. Corporate insiders own 0.60% of the company's stock.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
See Also
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report